ClearPoint Neuro, Inc. Customer Refund Liability, Current
ClearPoint Neuro, Inc. (CLPT) had Customer Refund Liability, Current of $0 as of 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:CustomerRefundLiabilityCurrent · last filed 2025-02-26
- 2024-12-31: Customer Refund Liability, Current $0.00.
- 2023-12-31: Customer Refund Liability, Current $0.00.
- 2022-12-31: Customer Refund Liability, Current $500.00K.
| Period end | Customer Refund Liability, Current |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-26 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-26 |
| 2022-12-31 | $500.00K 10-K · filed 2025-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |